342 related articles for article (PubMed ID: 26266204)
1. Tumour Angiogenesis and Angiogenic Inhibitors: A Review.
Yadav L; Puri N; Rastogi V; Satpute P; Sharma V
J Clin Diagn Res; 2015 Jun; 9(6):XE01-XE05. PubMed ID: 26266204
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.
Dell'Eva R; Pfeffer U; Indraccolo S; Albini A; Noonan D
Endothelium; 2002; 9(1):3-10. PubMed ID: 12901356
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenesis in cancer therapeutics: the magic bullet.
Oguntade AS; Al-Amodi F; Alrumayh A; Alobaida M; Bwalya M
J Egypt Natl Canc Inst; 2021 Jul; 33(1):15. PubMed ID: 34212275
[TBL] [Abstract][Full Text] [Related]
4. Antineovascular therapy, a novel antiangiogenic approach.
Shimizu K; Asai T; Oku N
Expert Opin Ther Targets; 2005 Feb; 9(1):63-76. PubMed ID: 15757482
[TBL] [Abstract][Full Text] [Related]
5. Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy.
Elebiyo TC; Rotimi D; Evbuomwan IO; Maimako RF; Iyobhebhe M; Ojo OA; Oluba OM; Adeyemi OS
Cancer Treat Res Commun; 2022; 32():100620. PubMed ID: 35964475
[TBL] [Abstract][Full Text] [Related]
6. κ Opioid receptor ligands regulate angiogenesis in development and in tumours.
Yamamizu K; Hamada Y; Narita M
Br J Pharmacol; 2015 Jan; 172(2):268-76. PubMed ID: 24417697
[TBL] [Abstract][Full Text] [Related]
7. The rationale and future potential of angiogenesis inhibitors in neoplasia.
Gasparini G
Drugs; 1999 Jul; 58(1):17-38. PubMed ID: 10439927
[TBL] [Abstract][Full Text] [Related]
8. Role of angiogenesis in tumor growth and metastasis.
Folkman J
Semin Oncol; 2002 Dec; 29(6 Suppl 16):15-8. PubMed ID: 12516034
[TBL] [Abstract][Full Text] [Related]
9. Novel anti-angiogenic therapies for malignant gliomas.
Norden AD; Drappatz J; Wen PY
Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
[TBL] [Abstract][Full Text] [Related]
10. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo.
Westphal JR; Van't Hullenaar R; Peek R; Willems RW; Crickard K; Crickard U; Askaa J; Clemmensen I; Ruiter DJ; De Waal RM
Int J Cancer; 2000 Jun; 86(6):768-76. PubMed ID: 10842189
[TBL] [Abstract][Full Text] [Related]
12. Tumour angiogenesis: a novel therapeutic target in patients with malignant disease.
O'Byrne KJ; Steward WP
Expert Opin Emerg Drugs; 2001 Apr; 6(1):155-74. PubMed ID: 15989502
[TBL] [Abstract][Full Text] [Related]
13. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
14. Specific chemotherapeutic agents induce metastatic behaviour through stromal- and tumour-derived cytokine and angiogenic factor signalling.
Liu G; Chen Y; Qi F; Jia L; Lu XA; He T; Fu Y; Li L; Luo Y
J Pathol; 2015 Oct; 237(2):190-202. PubMed ID: 25988668
[TBL] [Abstract][Full Text] [Related]
15. Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges.
Siveen KS; Prabhu K; Krishnankutty R; Kuttikrishnan S; Tsakou M; Alali FQ; Dermime S; Mohammad RM; Uddin S
Curr Vasc Pharmacol; 2017; 15(4):339-351. PubMed ID: 28056756
[TBL] [Abstract][Full Text] [Related]
16. 'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples.
Kerbel RS; Viloria-Petit A; Klement G; Rak J
Eur J Cancer; 2000 Jun; 36(10):1248-57. PubMed ID: 10882863
[TBL] [Abstract][Full Text] [Related]
17. Targeting Angiogenesis in Cancer Treatments: Where do we Stand?
Petrovic N
J Pharm Pharm Sci; 2016; 19(2):226-38. PubMed ID: 27518172
[TBL] [Abstract][Full Text] [Related]
18. Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives.
Gacche RN
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189020. PubMed ID: 37951481
[TBL] [Abstract][Full Text] [Related]
19. Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology.
van Kempen LC; Leenders WP
Eur J Cell Biol; 2006 Feb; 85(2):61-8. PubMed ID: 16439306
[TBL] [Abstract][Full Text] [Related]
20. Angiostatin.
Cao Y; Xue L
Semin Thromb Hemost; 2004 Feb; 30(1):83-93. PubMed ID: 15034800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
